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Gaussian process (GP) covariance function is proposed as a
matching tool in GPMatch within a full Bayesian framework
under relatively weaker causal assumptions. Thematching
is accomplished by utilizing GP prior covariance function
to define matching distance. We show that GPMatch pro-
vides a doubly robust estimate of the averaged treatment
effect (ATE) much like the G-estimation, the ATE is correctly
estimated when either conditions are satisfied: 1) the GP
mean function correctly specifies potential outcomeY (0); or
2) the GP covariance function correctly specifiesmatching
structure. Simulation studies were carried out without as-
suming any knownmatching structure nor functional form
of the outcomes. The results demonstrate that GPMatch en-
joys well calibrated frequentist properties, and outperforms
manywidely usedmethods including Bayesian Additive Re-
gression Trees. The case study compares effectiveness of
early aggressive use of biological medication in treating chil-
dren with newly diagnosed Juvenile Idiopathic Arthritis, us-
ing data extracted from electronic medical records.
K E YWORD S
Matching, Doubly Robust (DR) estimator, Marginal Structural
Model (MSM), g-estimation, Directed Acyclic Graphic (DAG)
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2 HUANG, B. ET AL.
1 | INTRODUCTION
Data from nonrandomized experiments, such as registry and electronic records, are becoming indispensable sources
for answering causal inference questions in health, social, political, economics andmany other disciplines. Under the
assumptions of ignorable treatment assignment and distinct model parameters governing the science and treatment
assignment mechanisms, Rubin (1978) showed the Bayesian inference of causal treatment effect can be approached by
directly outcomemodeling, treating it as amissing potential outcome problem. Direct modeling is able to utilize the
many Bayesian regressionmodeling techniques to address complex data type and data structures, such as examples in
Hirano et al. (2000), Zajonc (2012), Imbens and Rubin (1997) and Baccini et al. (2017).
Parameter rich Bayesian modeling techniques are particularly appealing as it does not presume an known func-
tional form, thusmay helpmitigate potential model miss-specification issues. Hill (2011) suggested Bayesian additive
regression tree (BART) can be used for causal inference, and showed it producedmore accurate estimates of average
treatment effects compared to propensity score matching, inverse propensity weighted estimators, and regression
adjustment in the nonlinear setting, and performed as well under the linear setting. Others have used Gaussian Process
in conjunction with Dirichlet Process priors, e.g. Roy et al. (2016) and Xu et al. (2016). Roy et al. (2017) devised enriched
Dirichlet Process priors tacklingmissing covariate issues. However, naive use of regression techniques could lead to
substantial bias in estimating causal effect as demostrated in Hahn et al. (2018a).
The search for ways of incorporating propensity of treatment selection into the Bayesian causal inference has been
long standing. Including propensity score (PS) as a covariate into the outcomemodel may be a natural way. However,
joint modeling of outcome and treatment selectionmodels leads to a “feedback” issue, and a two-stage approachwas
suggested byMcCandless et al. (2010), Zigler et al. (2013) andmany others. Discussion about whether the uncertainty
of the first step propensity scoremodeling should be taken into account when obtaining the final result in the second
step can be found in Hill and Reiter (2006), Ho et al. (2007), Rubin and Stuart (2006), Rubin and Thomas (1996) for
details. Saarela et al. (2016) proposed an approximate Bayesian approach incorporating inverse probability treatment
assignment probabilities as importance-sampling weights inMonte Carlo integration. It offers a Bayesian version to the
augmented inverse probability treatment weighting (AIPTW). Hahn et al. (2017) suggested incorporating estimated
treatment propensity into the regression to explicitly induce covariate dependent prior in regression model. These
methods all require a separate step of treatment propensity modeling, thus may suffer if the propensity model is
mis-specified.
Matching is one of themost sought-aftermethod used for designing observational study to answer causal questions.
Matching experimental units on their pre-treatment assignment characteristics helps to remove the bias by ensuring
the similarity or balance between the experimental units of the two treatment groups. Matchingmethods impute the
missing potential outcome with the value from the nearest match or the weighted average of the values within the
nearby neighborhood defined by (a chosen value) caliper. Matching onmultiple covariates could be challenging when
the dimension of the covariates are large. For this reason, matching is often performed using the estimated propensity
score (PS) or by theManhalanobis distance (MD). The idea is, under the no unmeasured confounder setting, matching
induces balance between the treated and untreated groups. Therefore, it serves to transform a nonrandomized study
into a pseudo randomized study. There aremany different matching techniques, a comprehensive review is provided in
Stuart (2010). A recent study by King and Nielsen (Forthcoming) compared the PSmatching with theMDmatching
and suggests that PSmatching can result more biased and less accurate estimate of averaged causal treatment as the
precision of matching improves, while theMDmatching is showing improved accuracy. Common tomatchingmethods,
the data points without amatch are discarded. Such a practicemay lead to a sample no longer representative of the
target population. A user-specified caliper is often required, but different calipers could lead to very different results.
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Furthermore, matching on amiss-specified PS could lead to invalid causal inference results.
Rubin (1973) suggested that the combination of matching and regression is a better approach than using either
of them alone. Ho et al. (2007) advocated matching as nonparametric preprocessing for reducing dependence on
parametric modeling assumptions. Gutman and Rubin (2017) examined different strategies of combining the prepro-
cessedmatching with a regressionmodeling of the outcome through extensive simulation studies. They demonstrated
that some commonly used causal inferencemethods have poor operating characteristics, and suggested regression
modeling after pre-processedmatching works better. To our knowledge, no existing method can accomplishmatching
and regressionmodeling in a single step.
Gaussian process (GP) prior has beenwidely used to describe biological, social, financial and physical phenomena,
due to its ability to model highly complex dynamic system and its many desirable mathematical properties. Recent
literature, e.g.Choi andWoo (2013) and Choi and Schervish (2007), has established posterior consistency for Bayesian
partially linear GP regressionmodels. Bayesianmodeling with GP prior can be viewed as amarginal structural model
where the potential outcome under the non-intervention conditionY (0) is modeled non-parametrically. It allows for
predicting themissing response by aweighted sum of observed data, with larger weights assigned to those in closer
proximity but smaller to those further away, much like amatching procedure. This motivated us to consider using GP
prior covariance function as amatching tool for Bayesian causal inference.
The idea of utilizingGP prior in Bayesian approach to causal inference is not new. Examples can be found in Roy et al.
(2016) for addressing heterogeneous treatment effect, in Xu et al. (2016) for handling dynamic treatment assignment,
and in Roy et al. (2017) for tacklingmissing data. While these studies demonstrated GP prior could be used to achieve
flexible modeling and tackle complex setting, no one has considered GP as a matching tool. This study adds to the
literature in several ways. First, we offer a principled approach to Bayesian causal inference utilizingGP prior covariance
function as amatching tool, which accomplishesmatching and flexible outcomemodeling in a single step. Second, we
provide relaxed causal assumptions than the widely adopted assumptions from the landmark paper by Rosenbaum
and Rubin (1983). By admitting additional random errors in outcomes and in the treatment assignment, these new
assumptions fit more naturally within Bayesian framework. Under these weaker causal assumptions, GPMatchmethod
offers a doubly robust approach in the sense that the averaged causal treatment effect is correctly estimated when
either one of the conditions are met : 1) when the mean function correctly specifies theY (0); or 2) the covariance
functionmatrix correctly specifies thematching structure. At last, the proposedmethod has been implemented in an
easy-to-use publicly available on-line application (https://pcats.research.cchmc.org/).
The rest of the presentation is organized as follows. Section 2 describes methods, where we present problem setup,
causal assumptions, and themodel specifications. The utility of GP covariance function as amatching tool is presented
in Section 3, followed by discussions of its doubly robustness property. Simulation studies are presented in Section
4. Simulations are designed to represent the real world setting where the true functional form is unknown, including
the well-known simulation design suggested by Kang and Schafer (2007). We compared the GPMatch approachwith
some commonly used causal inferencemethods, i.e. linear regression with PS adjustment, AIPTW, and BART, without
assuming any knowledge of the true data generatingmodels. The results demonstrate that the GPMatch enjoys well
calibrated frequentist properties, and outperformsmanywidely usedmethods under the dual miss-specification setting.
Section 5 presents a case study, examining the comparative effectiveness of an early aggressive use of biological
medication in treating childrenwith recent diagnosed juvenile idiopathic arthritis (JIA). Section 6 presents summary,
discussions and future directions.
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F IGURE 1 TheDirected Acyclic Graphic (DAG) Presentation of the Problem Setup
2 | METHOD
2.1 | Problem Setup andNotations
The problem setup is depicted in the directed acyclic graphic (DAG), where the rectangular nodes aremeasured and
oval nodes are latent or unmeasured variables. TheX andV are observed covariates, andY is the observed outcome.
The treatment assignment (A = 0/1) is a binary indicator, where 0 indicating comparator or the nature occurring
condition and 1 indicates intervention. Correspondingly, the potential outcomes (Y (0),Y (1)), are two latent variables.
The unmeasured covariates are denoted byU0,U1,U2, representing three types of unmeasured covariates forY (0),Y (1)
and A correspondingly. The potential outcomeY (0) under the controlled condition is determined jointly byX a p-
dimensional andV a q-dimensional vector of the observed covariates plus a unmeasured covariateU0 . Thus, (X,V ,U0)
are prognostic variables. Similarly, the potential outcomeY (1) under the intervention condition is determined jointly by
the observed covariates (X,V ) and the unobserved covariates (U0,U1). The observed outcomeY is a noisy version
of the corresponding potential outcomes, with an error term . The treatment is assigned according to an unknown
propensity score, which is determined by the baseline covariatesV andU2. The observed baseline covariatesXand
V could be overlapping, whereas different symbols are used to distinguish their roles in sciencemechanisms and the
treatment assignment process respectively. For example, X could include patient age, gender, genetic makeup, family
disease history, past and current medication use as well laboratory results and other disease characteristics, which are
directly related to the prognosis of the disease. The V could include the above X variable, as well as other considerations
to the treatment decisions including insurance, social economic status of patient family, education and clinical centers.
Most of these important X and V covariates are available in a patient registry and electronic medical records, thus are
observable. Other factors could play a role in treatment decisions, such as patient and clinician’s personal preferences,
culture believes and past experiences. However, they are almost never recorded. These factors are collective referred
asU2. The residual terms of responses (.U0,U1) can be overlapping or correlated, the corresponding links are omitted
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in the Figure 1 for better visual presentation.
The DAG can be expressed by a set of structural equationmodels:
Yi = AiY
(1)
i
+ (1 − Ai )Y (0)i + i ,
Y
(a)
i
= f (0)(xi,vi) + a(τ(xi) + u1i ) + u0i
P r (Ai ) = pi(vi ,u2i )
(1)
where E (i ) = 0 and E (uk i ) = 0, for k = 0, 1, 2. To ensure the causal treatment effect can be estimated without bias,
the following condition must be true: ⊥(Y (0),Y (1)), (U0,U1)⊥A |X,V , U2⊥ andU2⊥Y |A,X,V . Violation of any of
these conditional independence condition can open up the back-door path fromY toA (Pearl (2009)). The f (0)(·), f (1)(·)
and pi(·) are unknown functions that describes the potential outcome sciencemechanism and treatment assignment
process. The sample averaged treatment effect of all individual level effect τi = τ(xi ) + u1i , τ = 1n ∑i τi is the parameter
of interest, which is referred as the averaged treatment effect (ATE).
2.2 | The Causal Assumptions
The causal assumptions are necessary to ensure unbiased estimate of casual treatment effect. The causal assumptions
are presented in the DAG and the structural equation (1). Notice that the DAG includes three types of unmeasured
covariates, whereU0 indicates unknown correlation between the pair of potential outcomes,U1 a potential lurking
variable, and U2 a potential confounding variable. Under the conditional independence conditions, the observed
covariates (X,V ) is a minimum sufficient set for identifying causal treatment effect. Further, with assuming distinct
model parameters, it is relatively straight forward to see that the posterior of the potential outcomes can be derived
directly by
[Y (0),Y (1) |A,X,V ,Y ] = [Y ,Y
(0),Y (1) |A,X,V ]
[Y |A,X,V ] .
Comparing to the widely adopted causal assumptions laid out in the landmark paper by the Rosenbaum and Rubin
(1983) (RR), the DAG presents a weaker version of causal assumptions :
CA1. Instead of the stable unit treatment value assumption (SUTVA), we assume stable unit treatment value expecta-
tion assumption (SUTVEA). Specifically,
(i) The consistency assumption of RR requires the observed outcome is an exact copy of the potential outcome,
i.e.Yi =Y (0)i (1−Ai )+Y (1)i Ai . Instead, onlyY⊥X,V |(A,Y (0),Y (1)) is required. In otherwords, we consider the
observed outcome is a noisy copy of the potential outcomewhere the expectation of the observed outcome
E (Yi ) =Y (0)i (1 − Ai ) +Y
(1)
i
Ai .
(ii) The no interference assumption of RR requires the potential outcomes of one experiment unit is not influ-
enced by the potential outcomes of another experiment unit, i.e.Y (a)
i
⊥Y (b)
j
. Instead, we assume the observed
outcomes from different units are conditional independence given the observed covariatesYi⊥Yj |A,X,V
The SUTVEA assumption acknowledges existence of residual random error in the outcomemeasure. The observed
outcomesmay differ from the corresponding true potential outcomes due to somemeasurement errors. In addition,
the observed outcomes could differ when treatment received deviates from its intended version of treatment.
For example, outcomes could differ by the timing of the treatment, pre-surgery preparation procedure or the
concomitant medication. In addition, we consider the potential outcomes from different experimental units may be
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correlated, where the correlations are determined by the covariates. Since only one outcome could be observed
out of all potential outcomes, the causal inference presents a highly structured missing data setup where the
correlations between (Y (1)
i
,Y
(0)
i
) are not directly identifiable. Admitting residual errors and allowing for explicit
modeling of the covariance structure, the new assumptions could facilitate better statistics inference.
CA2. Similarly as in RR, we assume ignorable treatment assignment assumption [Y (a) |A = 1,X,V ] = [Y (a) |A =
0,X,V ], for a = 0, 1. That is the marginal distribution of a potential outcome can be obtained by modeling the
observed covariates only, indepedent from the treatment assignment. As depicted inDAG, presence of unmeasured
confounder is admissible, as long as the back-door path fromY to A is blocked by the observed covariates. In
practice, it is almost never possible for us to capture all the considerations factored into a treatment decisions, such
as personal preferences and past experiences. However, it is reasonable to consider the uncounted residual error
in treatment assignment, conditional on the observed covariates (e.g. patient demographics, insurance, disease
characteristics, laboratory andmedical diagnostic tests), is not related to the potential outcomes.
CA3. Positivity Assumption. Same as in RR, we assume every sample unit has nonzero probability of being assigned
into either one of the treatment arms, i.e. 0 < P r (Ai |xi, vi) < 1 for universalAlt(xi, vi). This assumption is adopted to ensure
the equipoise of the causal inference.
2.3 | The GPMatchModel Specifications
Marginal structural model (MSM) is a widely adoptedmodeling approach to causal inference, which serves as a natural
framework for Bayesian causal inference. TheMSM specifies
Y
(1)
i
=Y (0)
i
+ Ai τi .
Without prior knowledge about the true functional form, we letY (0)
i
∼ GP (µf ,K), where themean function µf maybe
modeled by a parametric regression equation, andK defines the covariance function of the GP prior. Specifically,
GPMatch is proposed as a partially linear Gaussian process regression fitting to the observed outcomes,
Yi = fi (xi,vi) + Ai τ(xi) + i , (2)
where
fi (xi,vi) = µf (xi) + η(vi),
ηi (vi) ∼ GP (0,K),
i ∼ N (0,σ0),
i ⊥ ηi .
Here, wemay letµf = ((1,Xi ′)β )n×1, whereβ is a (1 + p) dimension parameter vector of regression coefficients for
the mean function. This is to allow for implementing any existing knowledge about the prognostic determinants to
the outcome. Also, let τ =
(
(1,X′
i
)α
)
n×1
to allow for potential heterogeneous treatment effect, whereα is a (1 + p)
dimension parameter vector of regression coefficients for the treatment effect.
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LetYn = (Yi )n×1, themodel (2) can be re-expressed in amultivariate representation
Yn |A,X,V,γ ∼ MVN (Z′γ,Σ), (3)
whereZ′ = (1,X′
i
,Ai ,Ai ×X′i)n×(2+2p), γ = (β,α), Σ = (σi j )n×n , with σi j = K (vi,vj ) + σ20 δi j . The δi j is the Kronecker
function, δi j = 1 if i = j , and 0 otherwise.
Gaussian process can be considered as distribution over function. The covariance function K , where k i j =
Cov (ηi,ηj ), plays a critical role in GP regression. It can be used to reflect the prior belief about the functional form,
determining its shape and degree of smoothness. In the next section, we show for the data comes from an experimental
design where thematching structure is known, GP covariance could be formulated to reflect thematching structure.
Often, the exact matching structure is not available, a natural choice for the GP prior covariance functionK is the
squared-exponential (SE) function, where
K (vi ,vj ) = σ2f exp
(
−
q∑
k=1
|vk i − vk j |2
φk
)
, (4)
for i , j = 1, ..., n . The (φ1,φ2, ...,φq ) are the length scale parameters for each of the covariatesV .
There are several considerations in choosing the SE covariance function. The GP regression with SE covariance
can be considered as a Bayesian linear regressionmodel with infinite basis functions, which is able to fit a smoothed
response surface. Because of the GP’s ability to choose the length-scale and covariance parameters using the training
data, unlike other flexible models such as splines or the supporting vector machine (SVM), GP regression does not
require cross-validation(Rasmussen et al. (2006)). Moreover, SE covariance function provides a distancemetric that is
similar toMahalanobis distance, thus it could be served as amatching tool .
Themodel specification is completed by specification of the rest of priors.
γ ∼ MVN
(
0,ωσ2
l m
(ZZ′)−1
)
,
σ20 ∼ IG (a0, b0),
σ2
f
∼ IG (af , bf ),
φk ∼ IG (aφ , bφ ).
We setω = 106, aφ = bφ = 1, a0 = af = 2, b0 = bf = σ2l m/2,σ2l m is the estimated variance from a simple linear regression
model ofY onA andX for computational efficiency.
The posterior of the parameters can be obtained by implementing a Gibbs sampling algorithm: first sample the
covariate function parameters from its posterior distribution[Σ |Dat a,α,β]; then sample the regression coefficient
parameter associated with the mean function from its conditional posterior distribution [α,β |Dat a, Σ], which is a
multivariate normal distribution. The individual level treatment effect can be estimated by τˆ(xi ) = (1,Xi )′αˆ and the
averaged treatment effect is estimated by ˆAT E = ∑ni=1 τˆ(xi )n .
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3 | ESTIMATE ATE: CONNECTIONS WITH MATCHING AND G-ESTIMATION
3.1 | Design the GPCovariance Function as aMatching Tool
To demonstrate the utility of the GP covariance function as amatching tool, let us first consider design a covariance
function for the knownmatching data structure . In other words, we assume for any given sample unit, we knowwho
are thematching units. For simplicity, we consider fitting the data with a simple nonparametric version of the GPMatch,
Yn ∼ MVN (µ1n + τAn , Σ), (5)
where Σ =K + σ02In.
With knownmatching structure, the GP covariance functionmay present thematching structure by lettingK =
(k i j )n×n , where k i j = 1 indicates that the pair is completely matched, and k i j = 0 if unmatched. A common setting of
thematched data can be divided into several blocks of subsample within which thematched data points are grouped
together. Subsequently, wemay rewrite the covariance function of the nonparametric GPmodel (5) as a block diagonal
matrix where the l t h blockmatrix takes the form
Σl = σ
2 [(1 − ρ)In l + ρJn l ] ,
where σ2 = 1 + σ20 , ρ = 1/σ2andJn l denotes thematrix of ones. The parameter estimates of the regression parameters
can be derived by
(
µˆ
τˆ
)
=
[(
1′n
A′n
)
Σ−1
(
1n An
)]−1 ( 1′n
A′n
)
Σ−1Yn .
It follows that the estimated average treatment effect is,
τˆ =
1′nΣ−11nA′nΣ−1Yn −A′nΣ−11n1′nΣ−1Yn
1′nΣ−11nA′nΣ−1An −A′nΣ−11n1′nΣ−1An
,
Applying theWoodbury, Sherman &Morrison formula, we see Σ−1 is a block diagonal matrix of
Σ−1l =
1
σ2(1 − ρ)(1 − ρ + n l )
[(1 + (n − 1)ρ)In l − ρJn l ] .
Let Y¯l (a) denote the samplemean of outcome and n l (a) number of observations for the control (a = 0) and treatment
group (a = 1)within the l t h subclass, l = 1, 2, ..., L. The treatment effect can be expressed as a weighted sum of two
terms
τˆ = λτˆ1 + (1 − λ)τˆ0,
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where λ = ρD1
ρD1+(1−ρ)D2 , τˆ1 = C1D1 and τˆ0 = C2D2 ,
C1 =
∑
q l n l ×∑ q l n l (1)n l (0) (Y¯l (1) − Y¯l (0)) ,
C2 =
∑
qk n l (0) ×
∑
q l n l (1)Y¯l (1) −
∑
q l n l (1) ×
∑
q l n l (0)Y¯l (0),
D1 =
∑
q l n l ×∑ q l n l (1)n l (0),
D2 =
∑
q l n l (1) ×
∑
q l n l (0),
q l = (1 − ρ + ρn l )−1, n l = n l (0) + n l (1) and the summations are over l = 1, ..., L. To gain better insight into this estimator,
it should help to consider two special matching cases.
The first example is amatched twin experiment, where for each treated unit there is a untreated twin. Here, we
have a 2n × 2n block diagonal matrix Σ2n = In ⊗ J2 + σ0I2n . Thus, σ = 1 + σ20 , ρ = 11+σ2
0
, nk = 2, nk (0) = nk (1) = 1.
Substitute them into the treatment effect formula derived above, we have the same1:1matching estimator of treatment
effect τˆ = Y¯1 − Y¯0.
The second example is a stratified randomized experiment, where the true propensity of treatment assignment
is known. Suppose the strata are equal sized, Σ is a block diagonal matrix of IL ⊗ Jn + σ0In, where L is total
number of strata, the total sample size is N = Ln . It is straight forward to derive σ = 1 + σ20 , ρ = 11+σ2
0
, n l = n , for
l = 1, ..., L. Then the treatment effect is a weighted sum of τˆ0 = Y¯1 − Y¯0, and τˆ1 =
∑
n l (0)n l (1)
(
Y¯l (1)−Y¯l (0)
)∑
n l (0)n l (1) . Where the weight
λ =
N
∑
n l (0)n l (1)
n1n0σ
2
0
+N
∑
n l (0)n l (1)
is a function of sample sizes and σ20 . We can see when σ20 → 0, then λ → 1, τ → τˆ1. That is when
the outcomes are measured without error, the treatment effect is a weighted average of Y¯l (1) − Y¯l (0) , i.e. the groupmean
difference for each strata. As σ20 increase, λ decrease, then the estimate of τ puts moreweights on τˆ0. In other words,
GP estimate of treatment is a shrinkage estimator, where it shrinks the strata level treatment effect more towards the
overall samplemean difference when outcome variance is larger.
More generally, instead of 0/1match, the sample unitsmay bematched in various degrees. By letting the covariance
function takes a squared-exponential form, it offers a way to specify a distance matching, which closely resembles
Mahalanobis distancematching. For a pair of "matched" individuals, i.e. sample units with the same set of confounding
variables vi = vj , the model specifies Cor r (Y (0)i ,Y (0)j ) = 1. In other words, the "matched" individuals are expected
to be exchangeable. As the data points move further apart in the covariate space of Ωv , their correlation becomes
smaller. When the distant is far apart sufficiently, the model specifies Cor r (Y (0)
i
,Y
(0)
j
) ≈ 0 or "unmatched". Distinct
length scale parameters are used to allow for some confounder playingmore important roles than others inmatching.
Bymanipulating the values of vi and the corresponding length scale parameter, one could formulate the SE covariance
matrix to reflect the known 0/1 or various degree of matching structure. However, thematching structure is usually
unknown, andwas left to be estimated in the GPMatchmodel informed by the observed data.
3.2 | Doubly Robust Estimator of ATE
Theorem 1 Let the true treatment effect be τ∗, the GPMatch estimator is an unbiased estimate of the average treatment
effect, i.e. E (τi ) = τ∗, for i = 1, ...n,when either one of the condition is true: i) the GPmean function is correctly specified, i.e.
E (Z ′
i
γˆ) =Y (0)
i
; and ii) the GP covariance function is correctly specified, in the sense that, from the weight-space point of view of
GP regression, the weighted sum of treatment assignment A˜i correctly specifies the true treatment propensity pii = P r (Ai = 1).
Proof It is relatively straight forward for the first part. From the GPMatchmodel (3)Yn ∼ MVN (Z′γ,Σ), when the
linear regressionmodel fits the potential outcome correctly, i.e. E (Z ′
i
γˆ) =Y (0)
i
, then Σ degenerate to a diagonal matrix,
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suggesting all units are exchangeable. It follows E (τˆ) = τ∗, the treatment effect is correctly estimated.
The second part proceeds as the following. From theweight-space point of view, the GPMatchmodel predicts the
potential outcomes using a weighted sum of the observed outcomes,
Yˆi
(a)
=
∑n
j=1wi j (Yj − Aj τˆ) + aτˆ = Y˜i + (a − A˜i )τˆ, (6)
where Y˜i = ∑nj=1wi jYj and A˜i = ∑nj=1wi jAj , for i = 1, ..., n . The weight wi j = κi j∑j κi j where κi j = k(vj )′Σ−1, with
k(vj ) =
(
k (vj ,vi)
)
n×1. Thus, the Y˜i and A˜i could be considered as the Nadaraya-Watson estimator of the observed
outcomes and treatment assignment for each of the i-th unit in the sample. The estimate of treatment effect could
be obtained by solving ∂
∑n
i=1
(
Yi −Yˆi (Ai )
)2
∂τ = 0. We can see that, given a known GP covariance function, the GPMatch
treatment effect τˆ is anM-estimator that satisfies∑Ψi (τˆ) = 0, where
Ψi (τ) =
(
Yi − Y˜i − τ(Ai − A˜i )
) (Ai − A˜i ) = 0, (7)
Let the true propensity be pii = P r (Ai ), given the SUTVEA, we haveYi = AiY (1)i + (1 − Ai )Y (0)i + i . Given the true
treatment effect τ∗, it can be derived thatY (a)
i
= E (Yi ) + (a − pii )τ∗. When A˜i = pii is true, we haveΨi (τ) = [E (Yi ) − Y˜i +
(Ai − pii )(τ − τ∗) + i ](Ai − pii ). Thus, the GPMatch estimator is anM-estimator of ATE, where the estimating function is
conditionally unbiased, i.e. E (Ψi (τ∗)) = 0, for i = 1, ...n , when the GP covariance function is correctly specified in the
sense A˜i = pii .
Remark There are several remarks worth noting. First, the equation (7) is the empirical correlation of the residuals
from the outcome model and the residuals from the propensity of treatment assignment. Thus, GPMatch method
attempts to induce independence between two residuals - one from treatment selection process and one from the
outcomemodeling, just as the G-estimation equation suggested in Robins et al. (2000) and later in Vansteelandt et al.
(2014). Unlike the moment based G-estimator, which requires fitting of two separate models for the outcome and
propensity score, the GPMatch approach estimates covariance parameters the same time as it estimates the treatment
andmean function parameters. All within a full Bayesian framework.
Second, some data points may have treatment propensity close to 0 or 1. Those data usually are a cause of concern
in causal inference. In the naive regression type ofmodel, it may cause unstable estimationwithout added regularization.
In the IPTW type of method, a few data points may put undue influence over the estimation of treatment effect. In
matchingmethods, these data points often are discarded. Such practice could lead to sample no longer representative
of the target population. Like the G-estimation, we see in the equation (7), these data points receive zero or near zero
value of (Ai − A˜i ), putting very little influence over the estimation of treatment effect. Thus GPMatch shares the same
added robustness as the G-estimation against the lack of overlapping.
At last, the GPMatchmodel with a parametric mean function will be predicting the potential outcomes for any new
unit. Given themodel setup, two regression surfaces are predicted, where the distance between the two regression
surfaces represents the treatment effect. By including the treatment by covariate interactions, themodel could offer
conditional treatment effect as a function of the patient characteristics. Although themodel specifications presented in
section 2.3 suggest using a parametric linear regression equation formodeling the treatment effect τ(xi ), it is always
difficult to know if any higher order terms should be included in the model. One may consider introducing a few
fixed basis functions instead, estimation of the regression coefficients could inform existence of any nonlinear or
heterogeneous treatment effect.
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4 | SIMULATION STUDIES
To empirically evaluate the performances of GPMatch in a real world setting where neither matching structure nor
functional form of the outcome model are known, we conducted three sets of simulation studies to evaluate the
performances of the GPMatch approach to causal inference. The first set evaluated frequentist performance of
GPMatch. The second set compared the performance of GPMatch againstMDmatch, and the last set utilized thewidely
used Kang and Schafer design, comparing the performance of GPMatch against some commonly usedmethods.
In all simulation studies, the GPMatch approach used squared exponential covariate function, including only
treatment indicator in themean and all observed covariates into the covariance function, unless otherwise noted. The
results were compared with the following widely used causal inference methods: sub-classification by PS quantile
(QNT-PS); AIPTW, linear model with PS adjustment (LM-PS), linear model with spline fit PS adjustment (LM-sp(PS)) and
BART. Cubic B-splines with knots based on quantiles of PSwere used for LM-sp(PS).We also considered direct linear
regressionmodel (LM) as a comparison. The ATE estimates were obtained by averaging over 5000 posteriorMCMC
draws, after 5,000 burn in. For each scenario, three sample sizes were considered,N = 100, 200, and 400.The standard
error and the 95% symmetric interval estimate of ATE for each replicate were calculated from the 5,000MCMC chain.
For comparing performances of different methods, all results were summarized over N=100 replicates by the root
mean square error RMSE = √∑(τˆi − τ)2/N , median absolute errorMAE = medi an | τˆi − τ |, coverage rate Rc = (the
number of intervals that include τ)/N of the 95% symmetric posterior interval, the averaged standard error estimate
SEave =
∑
σˆi /N , where σˆi is the square root of the estimated standard deviation of τˆi , and the standard error of ATE
was calculated from 100 replicates SEemp = √∑(τˆi − ¯ˆτi )2/(N − 1).
4.1 | Well Calibrated Frequentist Performances
Let the observed covariate x ∼ N (0, 1) and the unobserved covariates {U0,U1,U2,  } ∼i i d N (0, 1). The potential out-
comewas generated by y (a) = ex + (1+γ1U1)× a +γ0U0 for a = 0, 1, where the true treatment effectwas 1+γ1U1i for the
i-th individual unit. The (U0,U1) are unobserved covariates. The treatment was selected for each individual following
l og i t (P (A = 1 |X )) = −0.2 + (1.8X )1/3 + γ2U 22 . The observed outcomewas generated by y |x , a = y (a) + γ3. Four param-
eter settings were considered for the combinations of {γ0, γ1, γ2, γ3 }: {0.5, 0, 0,√0.75}, {1, 0.15, 0, 0}, {0.5, 0, 0.7,√0.75},
and {1, 0.15, 0.7, 0}. In the 1st and 3r d settings, let τi = 1. In the 2nd and 4t h settings, the treatment effect τi ∼ (1, γ21 ),
varying among individual units. Except for the first setting, the simulation settings included unmeasured confounders
U1 and/orU2.
TABLE 1 Results of ATE Estimates under the Single Covariate Simulation Study Settings.
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
Setting 1: {γ0, γ1, γ2, γ3 } = {0.5, 0, 0,√0.75}
Gold 100 0.243 0.165 -0.066 0.93 0.216 0.235
200 0.149 0.109 0.027 0.94 0.150 0.147
400 0.123 0.087 -0.007 0.93 0.107 0.123
GPMatch 100 0.260 0.160 -0.038 0.93 0.242 0.258
200 0.161 0.116 0.033 0.97 0.167 0.159
400 0.122 0.085 -0.005 0.96 0.118 0.123
Setting 2: {γ0, γ1, γ2, γ3 } = {1, 0.15, 0, 0}
Continued on next page
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Table 1 – Continued from previous page
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
Gold 100 0.220 0.134 -0.011 0.92 0.213 0.221
200 0.159 0.098 0.001 0.94 0.151 0.159
400 0.107 0.077 -0.003 0.95 0.107 0.108
GPMatch 100 0.237 0.152 0.013 0.97 0.244 0.238
200 0.175 0.114 0.007 0.94 0.169 0.175
400 0.117 0.084 0.001 0.96 0.117 0.118
Setting 3: {γ0, γ1, γ2, γ3 } = {0.5, 0, 0.7,√0.75}
Gold 100 0.228 0.137 -0.016 0.92 0.214 0.228
200 0.154 0.099 0.005 0.94 0.151 0.155
400 0.113 0.078 0.001 0.94 0.107 0.114
GPMatch 100 0.231 0.156 0.009 0.96 0.237 0.232
200 0.166 0.107 -0.003 0.93 0.164 0.167
400 0.115 0.088 0.003 0.96 0.114 0.115
Setting 4: {γ0, γ1, γ2, γ3 } = {1, 0.15, 0.7, 0}
Gold 100 0.209 0.148 0.015 0.96 0.215 0.209
200 0.136 0.098 0.008 0.97 0.152 0.136
400 0.095 0.076 -0.002 0.98 0.107 0.095
GPMatch 100 0.226 0.140 0.022 0.97 0.238 0.226
200 0.164 0.105 0.024 0.98 0.169 0.163
400 0.104 0.073 0.009 0.96 0.114 0.104
RMSE = root mean square error; MAE = median absolute error; Bias = Estimate-True; Rc = Rate of coverage by the 95% interval estimate;
SEavg = average of standard error estimate from all replicate; SEemp = standard error of ATE estimates from all replicate;
Gold: Using the true outcome generatingmodel;
GPMatch: Bayesianmarginal structural model with Gaussian process prior, only treatment effect is included in themean function; covariance
function includesX .
The simulation results were summarized in the histogram of the posterior mean over the 100 replicates across
three sample sizes in Figure 2. Table 1 presented the results of GPMatch and the gold standard. The gold standard was
obtained by fitting the true outcome generating model. Under all settings, GPMatch presented well calibrated frequen-
tist properties with nominal coverage rate, and only slightly larger RMSE. The averaged bias, RMSE andMAE quickly
improve as sample size increases, and perform as well as the gold standard with the sample size of 400. Comparison of
the RMSE andMAEwith the results using other causal inferencemethods were presented in Figures S1 - S4.
4.2 | Compared toManhalanobis DistanceMatching
To compare the performances between theMDmatching andGPMatch, we considered a simulation studywith two
independent covariates x1, x2 from the uniform distributionU (−2, 2), treatment was assigned by lettingAi ∼ Ber (pii ),
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F IGURE 2 Distribution of the GPMatch Estimate of ATE, by Different Sample Sizes under the Single Covariate
Simulation Study Settings
where
l og i t pii = −x1 − x2 .
The potential outcomes were generated by
y
(a)
i
= 3 + 5a + x3
1i
,
Yi |Xi ,Ai ∼ N (y (Ai )i , 1).
The true treatment effect is 5. Three different sample sizes were consideredN= 100, 200 and 400. For each setting,
100 replicates were performed and the results were summarized.
We estimated ATE by applyingMahalanobis distancematching and GPMatch. TheMDmatching considered caliper
varied from 0.125 to 1 with step size 0.025, including both X1 and X2 in the matching using the functionMatch in R
packageMatching by Sekhon (2007). The averaged bias and its 95%-tile and 5%-tile were presented as vertical lines
corresponding to different calipers in Figure 3. To be directly comparable to the matching approach, the GPMatch
estimated the ATE by including treatment effect only inmodeling themean function, bothX1 andX2 were considered in
the covariance functionmodeling. The posterior results were generated with 5,000MCMC sample after 5,000 burn-in.
Its averaged bias (short dashed horizontal line) and 5% and 95%-tiles of the ATE estimate (long dashed horizontal
lines) were presented on the Figure 3 for each the sample sizes. Also presented in the Figure were the bias, median
absolute error (MAE), root mean square error (RMSE), and rate of coverage rate (Rc) summarized over 100 replicates of
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F IGURE 3 Simulation Study Results of comparing GPMatchwithManhalanobis DistanceMatchingMethods. The
circles are the averaged biases of estimates of ATE usingMahalanobis matching with corresponding calipers. The
corresponding vertical lines indicate the ranges between 5th and 95th percentiles of the biases. The horizontal lines are
the averaged ATE (short dashed line), and the 5th percentile and 95th percentile (long dashed line) of the biases of the
estimates fromGPMatch.
GPMatch. The bias from thematchingmethod increases with caliper; the width of interval estimate varies by sample
size and caliper. It reduces with increased caliper for the sample size of 100, but increases with increased caliper for
sample size of 400. In contrast, GPMatch produced amuchmore accurate and efficient estimate of ATE for all sample
sizes, with unbiased ATE estimate and nominal coverage rate. The 5% and 95%-tiles of ATE estimates are always smaller
than those from thematchingmethods for all settings considered, suggesting better efficiency of GPMatch.
4.3 | Performance under DualMisspecification
Following the well-known simulation design suggested by Kang and Schafer (2007), covariates z1, z2, z3, z4 were
independently generated from the standard normal distribution N (0, 1). Treatment was assigned by Ai ∼ Ber (pii ),
where
l og i t pii = −zi1 + 0.5zi2 − 0.25zi3 − 0.1zi4 .
The potential outcomes were generated for a = 0, 1 by
y
(a)
i
= 210 + 5a + 27.4zi1 + 13.7zi2 + 13.7zi3 + 13.7zi4,
Yi |Ai ,Xi ∼ N (y (Ai ), 1).
The true treatment effect is 5. To assess the performances of the methods under the dual miss-specifications, the
transformed covariates x1 = exp(z1/2), x2 = z2/(1 + exp(z1)) + 10, x3 =
(
z1z3
25 + 0.6
)3, and x4 = (z2 + z4 + 20)2 were
used in themodel instead of zi .
HUANG, B. ET AL. 15
TwoGPMatchmodels were considered: GPMatch1modeled the treatment effect only and GPMatch2modeled all
four covariatesX1 − X4 in themean functionmodel. Both includedX1 − X4 with four distinct length scale parameters.
The PS was estimated using two approaches including the logistic regression model on X1 − X4 and the covariate
balancing propensity scoremethod (CBPS, Imai and Ratkovic (2014)) applied toX1 − X4. The results corresponding
to both versions of PS were presented. Summaries over all replicates were presented in Table 2, and the RMSE and
theMAEwere plotted in Figure 4, for all methods considered. As a comparison, the gold standard which uses the true
outcome generatingmodel ofY ∼ Z1 − Z4 was also presented. Both GPMatch1 andGPMatch2 clearly outperforms
all the other causal inference methods in terms of bias, RMSE, MAE, Rc, and the SEave is closely matched to SEemp .
The ATE and the corresponding SE estimates improve quickly as sample size increases for GPMatch. In contrast, the
QNT_PS, AIPT, LM_PS and LM_sp(PS) methods show little improvement over increased sample size, so is the simple
LM. Improvements in the performance of GPMatch over existingmethods are clearly evident, with more than 5 times
accuracy in RMSE andMAE compared to all the othermethods except for BART. Even compared to the BART results,
the improvement in MAE is nearly twice for GPMatch2, and about 1.5 times for the GPMatch1. Similar results are
evident in RMSE and averaged bias. The lower than nominal coverage rate is mainly driven by the remaining bias, which
quickly reduces as sample size increases. Additional results are presented in Figure S5.
TABLE 2 Results of ATE Estimates using DifferentMethods under the Kang and Shafer DualMisspecification
setting.
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
Gold 100 0.224 0.150 0.011 0.95 0.225 0.225
200 0.171 0.125 -0.015 0.94 0.163 0.171
400 0.102 0.063 -0.015 0.96 0.112 0.102
GPMatch1 100 2.400 1.606 -1.254 0.92 2.158 2.057
200 1.663 1.309 -1.051 0.86 1.213 1.295
400 0.897 0.587 -0.564 0.86 0.673 0.701
GPMatch2 100 1.977 1.358 -0.940 0.91 1.672 1.748
200 1.375 1.083 -0.809 0.82 0.980 1.117
400 0.761 0.484 -0.432 0.87 0.567 0.629
QNT_PSa 100 7.574 6.483 -6.234 0.970 7.641 4.324
200 7.408 6.559 -6.615 0.860 5.199 3.353
400 7.142 6.907 -6.797 0.500 3.576 2.203
QNT_PSb 100 8.589 7.360 -7.177 0.970 7.541 4.744
200 8.713 8.121 -7.964 0.720 5.214 3.550
400 8.909 7.980 -8.399 0.300 3.607 2.987
LM 100 6.442 5.183 -5.556 0.65 3.571 3.277
200 6.906 6.226 -6.375 0.28 2.547 2.668
400 7.005 6.649 -6.702 0.04 1.796 2.048
AIPTWa 100 5.927 4.402 -4.330 0.72 3.736 4.067
200 19.226 5.262 -7.270 0.59 4.874 17.888
400 29.405 5.603 -9.676 0.36 6.115 27.908
AIPTWb 100 5.410 4.243 -3.659 0.77 3.780 4.005
200 5.780 5.075 -4.950 0.52 2.712 2.999
400 6.204 5.482 -5.652 0.24 2.105 2.569
Continued on next page
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Table 2 – Continued from previous page
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
LM_PSa 100 5.103 3.832 -4.091 0.74 3.420 3.066
200 5.392 4.648 -4.793 0.53 2.452 2.483
400 5.091 5.128 -4.787 0.19 1.706 1.741
LM_PSb 100 5.451 4.156 -4.528 0.72 3.427 3.051
200 5.891 4.981 -5.278 0.46 2.466 2.631
400 5.585 5.452 -5.272 0.13 1.726 1.852
LM_sp(PS)a 100 4.809 3.161 -3.598 0.79 3.165 3.207
200 4.982 4.152 -4.266 0.52 2.250 2.587
400 4.470 4.038 -4.127 0.23 1.559 1.727
LM_sp(PS)b 100 4.984 3.619 -3.806 0.77 3.095 3.233
200 5.237 4.374 -4.507 0.51 2.248 2.681
400 4.856 4.484 -4.494 0.18 1.585 1.851
BART 100 3.148 2.504 -2.491 0.79 2.163 1.935
200 2.176 1.870 -1.726 0.74 1.308 1.332
400 1.283 0.942 -0.997 0.71 0.757 0.812
a Propensity score estimated using logistic regression onX1 − X4 .
b Propensity score estimated using CBPS onX1 − X4 .
RMSE = root mean square error; MAE = median absolute error; Bias = Estimate-True; Rc = Rate of coverage by the 95% interval estimate;
SEavg = average of standard error estimate from all replicate; SEemp = standard error of ATE estimates from all replicate;
GPMatch1-2: Bayesian structural model with Gaussian process prior. GPMatch1 including only treatment effect, and GPMatch2 including
both treatment effect andX1 − X4 in themean function; both includingX1 − X4 in the covariance function.
QNT_PS: Propensity score sub-classification by quintiles.
AIPTW: augmented inversed probability of treatment weighting;
LM: linear regressionmodelingY ∼ X1 − X4;
LM_PS: linear regressionmodeling with propensity score adjustment.
LM_sp(PS): linear regressionmodeling with spline fit propensity score adjustment.
BART: Bayesian additive regression tree.
5 | A CASE STUDY
JIA is a chronic inflammatory disease, the most common autoimmune disease affecting the musculoskeletal organ
system, and a major cause of childhood disability. The disease is relatively rare, with an estimated incidence rate of
12 per 100,000 child-year (Harrold et al. (2013)). There are many treatment options. Currently, the two common
approaches are the non-biologic disease modifying anti-rheumatic drugs (DMARDs) and the biologic DMARDs. Limited
clinical evidence suggest that early aggressive use of biologic DMARDsmay bemore effective (Wallace et al. (2014)).
Utilizing data collected from a completed prospectively followed up inception cohort research study (Seid et al. (2014)),
a retrospective chart review collectedmedication prescription records for study participants captured in the electronic
health record system. This comparative study is aimed at understanding whether therapy using early aggressive
combination of non-biologic and biologic DMARDs is more effective than themore commonly adopted non-biologic
DMARDsmonotherapy in treating children with recently (<6months) diagnosed polyarticular course of JIA. The study
is approved by the investigator’s institutional IRB.
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F IGURE 4 The RMSE andMAE of ATE Estimates using DifferentMethods under the Kang and Shafer Simulation
Study Setting. GPMatch1-2: Bayesian structural model with Gaussian Process prior. GPMatch1 including only
treatment effect, and GPMatch2 including both treatment effect andX1 − X4 in themean function; andX1 − X4 are
included in the covariance function. QNT_PS: Propensity score sub-classification by quintiles. AIPTW: augmented
inverse probability of treatment weighting; LM: linear regressionmodelingY ∼ X1 − X4; LM_PS: linear regression
modeling with propensity score adjustment. LM_sp(PS): linear regressionmodeling with spline fit propensity score
adjustment
The primary outcome is the Juvenile Arthritis Disease Activity Score (JADAS) after 6 months of treatment, a
disease severity score calculated as the sum of four core clinical measures: physician’s global assessment of disease
activity (0-10), patient’s self-assessment of overall wellbeing (0-10), erythrocyte sedimentation rate (ESR, standardized
to 0-10), and number of active joint counts (AJC, truncated to 0-10). It ranges from 0 to 40, with 0 indicating no
disease activity. Out of the 75 patients receiving either non-biological or the early combination of biological and
non-biological DMARDs at baseline, 52 patients were treated by the non-biologic DMARDs and 23were treated by
the early aggressive combination DMARDs. The patients with longer disease duration, positive rheumatoid factor
(RF) presence, higher pain visual analog scale (VAS) and lower baseline functional ability as measured by the childhood
health assessment questionnaire (CHAQ), higher lost range of motion (LROM) and JADAS score are more likely to
receive the biologic DMARDs prescription. The propensity score was derived using the CBPSmethod applied to the
pre-determined important baseline confounders. The derived PS were able to achieve a desired covariate balance
within the 0.2 absolute standardizedmean difference (Figure 5), and comparable distributions in important confounders
(Figure S6).
The GPMatch model included the baseline JADAS, CHAQ, time since diagnosis at baseline, and time interval
between baseline and the six month follow-up visit in modelling the covariance function. These four covariates, along
with the binary treatment indicator and an indicator of positive test of rheumatoid factor were used in the partially
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F IGURE 5 Balance Check Results for the Cases Study
F IGURE 6 Case Study Trace Plot andHistogram
linear mean function part of the GPMatch. Applying the proposedmethod, GPMatch obtained the average treatment
effect of -2.90with standard error of 1.91, and the 95% credible interval of (-6.65, 0.79). Figure 6 presents the trace
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TABLE 3 Results of Case Study ATE Estimates with None-MatchingMethods
Method Estimate SD LL UL
Naïve -0.338 1.973 -4.205 3.529
QNT_PS -0.265 0.792 -1.817 1.286
AIPTW -0.639 2.784 -6.094 4.817
LM -2.550 1.981 -6.432 1.332
LM_PS -2.844 2.002 -6.767 1.079
LM_sp(PS) -1.664 2.159 -5.896 2.568
BART -2.092 1.629 -5.282 1.155
GPMatch -2.902 1.912 -6.650 0.789
SD = standard deviation; LL = lower limit; UL=upper limit;
Naïve: Student-T two group comparisons;
QNT_PS: Propensity score sub-classification by quintiles.
AIPTW: augmented inversed probability of treatment weighting;
LM: linear regressionmodelingY ∼ X ;
LM_PS: linear regression modeling with propensity score adjust-
ment.
LM_sp(PS): linear regression modeling with spline fit propensity
score adjustment;
BART: Bayesian additive regression tree;
GPMatch: Bayesian structural model with Gaussian process prior.
plot and histogram of the posterior distribution of the ATE estimate. The results suggest that, the early aggressive
combination of non-biologic and biologic DMARDs as the first line of treatment is more effective, leading to a nearly 3
point of reduction in JADAS six months after treatment, compared to the non-biologic DMARDs treatment to children
with a newly diagnosed disease. The results of ATE estimates by GPMatch, naive two group comparison and other
existing causal inferencemethods are presented in Table 3. The LM, LM_PS, LM_sp(PS) and AIPTW include the same five
covariates in themodel alongwith the treatment indicator. BART used the treatment indicator and those covariates.
While all results suggested effectiveness of an early aggressive use of biological DMARD, the naive, PS sub-classificiton
by quintiles, and AIPTW suggested amuch smaller ATE effect. The BART and PS adjusted linear regression produced
results that were closer to the GPMatch results suggesting 2 or 3 points reduction in the JADAS score if treated by the
early aggressive combination DMARDs therapy. None of the results were statistically significant at the 2-sided 0.05
level.
We also applied the covariatematchingmethod to the same dataset based on the same four baseline covariates.
Table 4 presents the results from using different caliper. As expected, as calipers narrow, the number of observations
being discarded increases. Since only 10 patients had RF positive, thus, when the calipers were set to 1 or smaller, we
cannot matching on RF positive anymore. Thus, for calipers smaller than 1, all subjects with positive RF were being
excluded. When calipers were set at 0.5, about 50% observations were discarded. When the calipers were set at 0.2, 62
out of 73 observations were discarded, rendering the results obtained from 11 observations only! The estimate of ATE
was sensitive to the choices of calipers, ranged from -6.59 to -3.12, making it difficult to interpret the study results.
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TABLE 4 Results of Case Study ATE Estimates withMatchingMethod in Case Study
Caliper 2 1 0.8 0.5 0.4 0.2
ATE -3.117 -4.043 -4.035 -5.577 -6.592 -3.864
SE 2.232 2.075 1.701 1.459 1.092 0.536
# of obs dropped 1 10 21 34 49 62
Standardizedmean difference between two treatment groups
BeforeMatch AfterMatch
JADAS0 0.675 0.215 0.078 0.079 0.035 0.079 -0.090
Time diagnosed 0.233 0.013 0.020 -0.006 -0.010 0.041 0.048
CHAQ 0.281 0.083 0.079 0.072 0.079 -0.054 -0.057
RF positive 0.643 0.000 0.000 NA* NA* NA* NA*
Note: *When the caliper is less than 1, all of the observations with positive RF are excluded.
6 | CONCLUSIONS AND DISCUSSIONS
Bayesian approaches to causal inference commonly consider it as amissing data problem. However, as suggested inDing
and Li (2018), the causal inference presents additional challenges that are unique in itself than themissing data alone.
Approaches not carefully address these unique challenges are vulnerable tomodel mis-specifications and could lead to
seriously biased results. When not considering the treatment-by-indication confounding, naive Bayesian regression
approaches could suffer from "regularity induced bias" (Hahn et al. (2018a) ). Because no more than one potential
outcome could be observed for a given individual unit, the correlation of (Y (1)
i
,Y
(0)
i
) is not directly identifiable, leading
to "inferential quandary" as suggested in Dawid (2000) . Extensive simulations presented in Kang and Schafer (2007);
Gutman and Rubin (2017); Hahn et al. (2018b) suggested poor operational characteristics observed in many widely
adopted causal inferencemethods.
The proposed GPMatchmethod offers a full Bayesian causal inference approach that can effectively address the
unique challenges inherent in causal inference. First, utilizing GP prior covariance function to model covariance of
observed data, GPMatch could estimate themissing potential outcomesmuch like thematchingmethod. Yet, it avoids
pitfalls of manymatchingmethods. No data is discarded, and no arbitrary caliper is required. Instead, themodel allows
the data to speak by itself via estimating length scale and variance parameters. The SE covariance function of GP
prior offers an alternative distancemetric, which closely resemblesMahalanobis distance. It matches data points by
the degree of matching proportional to the SE distance, without requiring specification of caliper. For this reason,
the GPMatch could utilize data information better thanmatching procedure. Different length scale parameters are
considered for different covariates used in defining SE covariance function. This allows the data to select the most
important covariates to bematched on, and acknowledge some variable is more important than others. While the idea
of using GP prior for Bayesian causal inference is not new. Utilizing GP covariance function as amatching device is a
unique contribution of this study. Thematching utility of GP covaraince function is presented analytically by considering
a setting whenmatching structure is known. We show that GPMatch enjoys doubly robust properties, in the sense that
it correctly estimate the averaged treatment effect when either one of the conditions is true: 1) themean function of
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the GPMatch correctly specifies the prognostic function of the potential outcomeY (0); and 2) the GP prior covariance
function correctly specifiesmatching structure. We show that GPMatch estimates the treatment effect by inducing
independence between two residuals: the residual from treatment propensity estimate and the residual from the
outcome estimate, much like the G-estimation method. Unlike the two-staged G-estimation, the estimations of the
parameters in covariance function and themean function for the GPMatch are performed simultaneously. Therefor,
GPMatch regression approach can integrate the benefits of the regressionmodel andmatchingmethod and offers a
natural way for Bayesian causal inference to address challenges unique to the causal inference problems. The robust
and efficient proprieties of GPMatch are well supported by the simulation results designed to reflect themost realistic
settings, i.e. no knowledge of matching or functional form of outcomemodel is available.
The validity of causal inference by GPMatch rests on aweaker version of causal assumptions depicted in the Fig.
1 DAG. Despite the fact that previous literature have questioned the SUTVA assumption (see stochastic consistency
suggestedbyCole andFrangakis (2009) andVanderWeele (2009), and treatment variationdiscussed inRubin (1978)), no
approach to our knowledge has explicitly acknowledged it as such. Rather, most of themethods imposing an overly rigid
assumption that the treatment from the real world as having exactly the samemeaning as those from the randomized
and tightly controlled experiments, and that the observed outcome is an exact copy of the corresponding potential
outcome. Here, our causal assumptions reflect more realistic setting that outcome could be measured with error,
and the treatment received by different individuals may vary, even though the treatment prescribed is identical. The
assumption of the ignorable treatment assignment is often used exchangeably with the assumption of no unmeasured
confounder in the currently literature. The ignorable treatment assignment assumption is necessary to ensure the
validity of causal inference obtained from the observed data. In Fig 1. DAG, we show that unmeasured confounders are
admissible under the ignorable treatment assumption. Specifically, it allows for existence ofU1 andU2 (both correlated
withA andY ), as long as they do not open up the back-door path from Y toA conditional of themeasured covariates. In
other words, the causal effect can be identifiedwithout bias if we could observe aminimum sufficient set that block the
back-door path fromY toA. Thus, it presents a weaker assumption than the assumption of no unmeasured confounder.
In case any potential violation of the causal assumptions is suspected, external information is needed and GPMatch can
be extended to incoporate such uncertainty. With a weaker version of causal assumptions and by explicitly modeling
themean and covariance functions, the GPMatch is more capable of defending against potential model misspecification
in the challenging real world setting.
Full Bayesianmodeling approach is particularly useful in comparative effectiveness research. It offers a coherent
and flexible framework for incorporating prior knowledge and synthesizing information from different sources. As a full
Bayesian causal inferencemodel, the GPMatch offers a very flexible and general approach to addressmore complex
data types and structures natural tomany causal inference problem settings. It can be directly extended to consider
multilevel or cluster data structure, and to accommodate complex type of treatment such asmultiple level treatment,
continuous or composite type of treatment. The model could be extend to time-varying treatment setting without
much difficulty by following the g-computation formula framework. The post-treatment confounding can be addressed
by incorporate the confounding variables into the modeling of mean function. We are already implementing these
extensions in an ongoing case study. Althoughwe focused on presenting GPMatch for estimating the average treatment
effect (ATE) in this study, the approach is directly applicable to estimation of averaged treatment effect in treated
(ATT) and averaged treatment effect in control (ATC). In addition, it can be readily used for modeling treatment effect
as a function of pre-specified treatment modifying factors. Sivaganesan et al. (2017) suggested a Bayesian decision
theory based approach for identifying subgroup treatment effect in a randomized trial setting. With GPMatch, the
same idea could be applied to identify subgroup treatment analyzing real world data. Studies are ongoing to evaluate its
performances for estimating heterogeneous treatment effect. The GP regression has been extended to general types of
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outcomes including binary and count data (Rasmussen (2004)). Future studies may further investigate its performance
under the general types of outcome and data structures. Our simulation focused on comparing with the commonly
used causal inferencemethod. Future studies may consider comparisons of our methodwith other advanced Bayesian
methods such as those proposed by Roy et al. (2017) and Saarela et al. (2016), as well as other advanced non-Bayesian
approaches like TargetedMLE (VanDer Laan and Rubin (2006)).
TheGPregression is a veryflexiblemodeling technique, but it is computationally expensive. The timecost associated
with GP regression increases at n3 rate, thus it can be challenging with large sample sizes. The Bayesian Gibbs Sampling
algorithm we have used makes it even more demanding in computational resources. Some literature has offered
solutions by applying GP to large data, such as Banerjee et al. (2008). Alternatively, onemay consider using Bayesian
Kernel regression as an approximation. Further studies are needed to improve the computational efficiency and to
consider variable selection. It iswell known the length scale parameter is hard to estimate. Researchers deriveddifferent
kinds of priors for GP, for example the objective prior in Berger et al. (2001), Kazianka and Pilz (2012), and Ren et al.
(2013). Gelfand et al. (2005) suggested using uniform prior for the inverse of the scale parameter in a spatial analysis,
butwe found that using a priorwith preference to smooth surfacewasmore suitable for our purpose. Researchers could
also blend their knowledge in the prior to obtain amore efficient estimate. Here we considered squared exponential
covariance function but different covariance function such asMatérn could also be considered. Simple block compound
symmetry with one correlation coefficient parameter could be used as an alternative covariancematrix. Such blocked
covariance set up could be useful particularly for a large sample size andwhere the data has a reasonable clustering
structure, such as in the case of amulti-site study. Future study will explore along this direction.
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1SUPPLEMENTAL TABLES AND F I GURES TO "GPMATCH : A BAYES IAN DOUBLY
ROBUST APPROACH TO CAUSAL INFERENCE WITH GAUSS IAN PROCESS
COVAR IANCE FUNCT ION AS A MATCH ING TOOL"
TABLE S1 Results of ATE Estimates from the Single Covariate Simulation Study Setting 1:
{γ0, γ1, γ2, γ3 } = {0.5, 0, 0,
√
0.75}.
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
GPMatch 100 0.26 0.16 -0.038 0.93 0.241 0.258
200 0.161 0.116 0.033 0.97 0.166 0.159
400 0.122 0.085 -0.005 0.96 0.118 0.123
QNT_PS 100 0.376 0.244 0.052 0.95 0.392 0.216
200 0.309 0.220 0.127 0.94 0.275 0.283
400 0.238 0.159 0.096 0.92 0.201 0.219
LM 100 0.409 0.216 -0.179 0.93 0.347 0.37
200 0.291 0.183 -0.119 0.89 0.25 0.266
400 0.28 0.169 -0.171 0.84 0.185 0.223
AIPTW1 100 0.82 0.341 -0.176 0.96 0.554 0.805
200 0.765 0.294 -0.209 0.98 0.504 0.74
400 0.753 0.251 -0.231 0.96 0.426 0.721
AIPTW2 100 0.411 0.236 -0.045 0.91 0.349 0.41
200 0.288 0.203 0.029 0.93 0.268 0.288
400 0.225 0.146 0.002 0.93 0.197 0.226
LM_PS1 100 0.367 0.239 -0.109 0.91 0.332 0.352
200 0.272 0.161 -0.051 0.91 0.246 0.268
400 0.198 0.13 -0.064 0.95 0.181 0.189
LM_PS2 100 0.366 0.201 -0.054 0.93 0.349 0.364
200 0.256 0.181 0.031 0.99 0.253 0.255
400 0.185 0.136 -0.004 0.95 0.186 0.186
LM_sp(PS1) 100 0.264 0.186 -0.054 0.91 0.241 0.26
200 0.156 0.102 0.023 0.97 0.167 0.155
400 0.127 0.086 -0.008 0.94 0.118 0.128
LM_sp(PS2) 100 0.267 0.175 -0.057 0.90 0.24 0.262
200 0.155 0.11 0.02 0.98 0.167 0.154
400 0.126 0.089 -0.01 0.94 0.118 0.126
BART 100 0.27 0.156 -0.026 0.95 0.257 0.27
200 0.185 0.145 0.048 0.95 0.178 0.18
400 0.133 0.084 0.016 0.97 0.125 0.133
RMSE = root mean square error; MAE = median absolute error; Bias = Estimate-True; Rc = Rate of coverage by the 95% interval estimate;
SEavg = average of standard error estimate from all replicate; SEemp = standard error of ATE estimates from all replicate;
GPMatch: Bayesian structural model with Gaussian process prior, only treatment effect is included in themean function; covariance function
includesX .
QNT_PS: Propensity score sub-classification by quintiles.
AIPTW1&AIPTW2: augmented inversed probability of treatment weighting.
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2LM_PS1 & LM_PS2: linear regressionmodeling with propensity score adjustment;
LM_sp(PS1) & LM_sp(PS2): linear regressionmodeling with spline fit propensity score adjustment;
BART: Bayesian additive regression tree.
Propensity scores are estimated using different logistic models, with AIPTW1, LM_PS1 & LM_sp(PS1) use PS estimated using logistic model
l og i tA ∼ X ; and AIPTW2, LM_PS2 & LM_sp(PS2) use PS estimated using logistic model l og i tA ∼ X 1/3 . QNT_PS using either PS estimates
produces identical results.
TABLE S2 Results of ATE Estimates from the Single Covariate Simulation Study Setting 2:
{γ0, γ1, γ2, γ3 } = {1, 0.15, 0, 0}.
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
GPMatch 100 0.237 0.152 0.013 0.97 0.243 0.238
200 0.175 0.114 0.007 0.94 0.169 0.175
400 0.117 0.084 0.001 0.96 0.117 0.118
QNT_PS 100 0.436 0.271 0.089 0.95 0.466 0.429
200 0.301 0.210 0.103 0.98 0.287 0.284
400 0.254 0.171 0.096 0.88 0.209 0.236
LM 100 0.427 0.255 -0.214 0.93 0.399 0.371
200 0.348 0.174 -0.164 0.93 0.26 0.309
400 0.318 0.166 -0.198 0.81 0.191 0.25
AIPTW1 100 0.933 0.378 -0.226 0.96 0.671 0.91
200 3.853 0.246 -0.478 0.95 0.861 3.842
400 1.25 0.213 -0.396 0.98 0.565 1.192
AIPTW2 100 0.413 0.306 -0.029 0.96 0.411 0.414
200 0.345 0.156 -0.001 0.96 0.281 0.346
400 0.244 0.124 -0.021 0.97 0.221 0.244
LM_PS1 100 0.352 0.265 -0.087 0.97 0.368 0.343
200 0.273 0.181 -0.055 0.93 0.251 0.269
400 0.192 0.11 -0.082 0.92 0.188 0.174
LM_PS2 100 0.337 0.251 -0.018 0.98 0.397 0.339
200 0.252 0.154 -0.004 0.97 0.262 0.253
400 0.175 0.101 -0.004 0.98 0.192 0.176
LM_sp(PS1) 100 0.237 0.158 -0.006 0.97 0.242 0.238
200 0.171 0.109 -0.004 0.94 0.169 0.172
400 0.118 0.083 -0.003 0.96 0.118 0.118
LM_sp(PS2) 100 0.248 0.163 0.002 0.96 0.243 0.249
200 0.171 0.103 -0.001 0.95 0.169 0.172
400 0.116 0.087 -0.006 0.96 0.118 0.117
Bart 100 0.286 0.176 0.054 0.95 0.266 0.283
200 0.182 0.115 0.034 0.96 0.18 0.18
400 0.161 0.085 0.01 0.93 0.127 0.161
RMSE = root mean square error; MAE = median absolute error; Bias = Estimate-True; Rc = Rate of coverage by the 95% interval estimate;
SEavg = average of standard error estimate from all replicate; SEemp = standard error of ATE estimates from all replicate;
GPMatch: Bayesian structural model with Gaussian process prior, only treatment effect is included in themean function; covariance function
includesX .
3QNT_PS: Propensity score sub-classification by quintiles.
AIPTW1&AIPTW2: augmented inversed probability of treatment weighting.
LM_PS1 & LM_PS2: linear regressionmodeling with propensity score adjustment;
LM_sp(PS1) & LM_sp(PS2): linear regressionmodeling with spline fit propensity score adjustment;
BART: Bayesian additive regression tree.
Propensity scores are estimated using different logistic models, with AIPTW1, LM_PS1 & LM_sp(PS1) use PS estimated using logistic model
l og i tA ∼ X ; and AIPTW2, LM_PS2 & LM_sp(PS2) use PS estimated using logistic model l og i tA ∼ X 1/3 . QNT_PS using either PS estimates
produces identical results.
TABLE S3 Results of ATE Estimates from the Single Covariate Simulation Study Setting 3:
{γ0, γ1, γ2, γ3 } = {0.5, 0, 0.7,
√
0.75}.
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
GPMatch 100 0.231 0.156 0.009 0.96 0.238 0.232
200 0.166 0.107 -0.003 0.93 0.164 0.167
400 0.115 0.088 0.003 0.96 0.114 0.115
QNT_PS X 100 0.554 0.443 0.408 0.91 0.442 0.377
200 0.364 0.282 0.263 0.92 0.298 0.252
400 0.328 0.278 0.260 0.77 0.211 0.201
LM 100 0.364 0.256 0.121 0.95 0.350 0.345
200 0.279 0.179 0.155 0.88 0.256 0.233
400 0.230 0.192 0.164 0.87 0.181 0.162
AIPTW1 100 0.533 0.432 0.413 0.81 0.355 0.339
200 0.544 0.512 0.462 0.58 0.282 0.289
400 0.504 0.466 0.469 0.24 0.196 0.185
AIPTW2 100 0.507 0.430 0.401 0.79 0.322 0.311
200 0.481 0.444 0.421 0.54 0.234 0.234
400 0.456 0.424 0.428 0.23 0.162 0.157
LM_PS1 100 0.374 0.234 0.213 0.80 0.261 0.309
200 0.382 0.281 0.289 0.67 0.191 0.251
400 0.335 0.282 0.288 0.44 0.133 0.171
LM_PS2 100 0.500 0.384 0.386 0.84 0.339 0.319
200 0.495 0.432 0.427 0.61 0.251 0.251
400 0.464 0.416 0.433 0.30 0.177 0.166
LM_sp(PS1) 100 0.235 0.162 -0.001 0.94 0.235 0.237
200 0.170 0.114 -0.012 0.92 0.165 0.170
400 0.115 0.090 0.002 0.96 0.115 0.116
LM_sp(PS2) 100 0.232 0.161 0.005 0.97 0.238 0.233
200 0.167 0.114 -0.008 0.95 0.167 0.167
400 0.115 0.094 0.002 0.97 0.117 0.115
Bart 100 0.274 0.191 0.114 0.97 0.265 0.251
200 0.195 0.116 0.071 0.93 0.188 0.182
400 0.138 0.095 0.057 0.94 0.136 0.126
RMSE = root mean square error; MAE = median absolute error; Bias = Estimate-True; Rc = Rate of coverage by the 95% interval estimate;
4SEavg = average of standard error estimate from all replicate; SEemp = standard error of ATE estimates from all replicate;
GPMatch: Bayesian structural model with Gaussian process prior, only treatment effect is included in themean function; covariance function
includesX .
QNT_PS: Propensity score sub-classification by quintiles.
AIPTW1&AIPTW2: augmented inversed probability of treatment weighting.
LM_PS1 & LM_PS2: linear regressionmodeling with propensity score adjustment;
LM_sp(PS1) & LM_sp(PS2): linear regressionmodeling with spline fit propensity score adjustment;
BART: Bayesian additive regression tree.
Propensity scores are estimated using different logistic models, with AIPTW1, LM_PS1 & LM_sp(PS1) use PS estimated using logistic model
l og i tA ∼ X ; and AIPTW2, LM_PS2 & LM_sp(PS2) use PS estimated using logistic model l og i tA ∼ X 1/3 . QNT_PS using either PS estimates
produces identical results.
TABLE S4 Results of ATE Estimates from the Single Covariate Simulation Study Setting 4:
{γ0, γ1, γ2, γ3 } = {1, 0.15, 0.7, 0}.
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
GPMatch 100 0.226 0.140 0.022 0.97 0.238 0.226
200 0.164 0.105 0.024 0.98 0.169 0.163
400 0.104 0.073 0.009 0.96 0.114 0.104
QNT_PS 100 0.579 0.477 0.437 0.90 0.452 0.382
200 0.369 0.312 0.279 0.87 0.308 0.244
400 0.300 0.268 0.245 0.78 0.199 0.174
LM 100 0.323 0.236 0.175 0.96 0.362 0.273
200 0.292 0.214 0.187 0.90 0.259 0.226
400 0.213 0.170 0.165 0.87 0.174 0.136
AIPTW1 100 0.596 0.456 0.461 0.78 0.377 0.380
200 0.523 0.457 0.473 0.48 0.262 0.223
400 0.474 0.459 0.433 0.32 0.210 0.192
AIPTW2 100 0.541 0.452 0.438 0.76 0.335 0.319
200 0.488 0.451 0.446 0.48 0.231 0.199
400 0.418 0.407 0.393 0.31 0.166 0.143
LM_PS1 100 0.398 0.264 0.256 0.84 0.266 0.307
200 0.376 0.297 0.288 0.64 0.191 0.244
400 0.340 0.305 0.303 0.35 0.132 0.155
LM_PS2 100 0.563 0.421 0.444 0.81 0.352 0.349
200 0.498 0.471 0.453 0.50 0.253 0.207
400 0.411 0.400 0.388 0.32 0.175 0.135
LM_sp(PS1) 100 0.226 0.140 0.004 0.970 0.237 0.227
200 0.138 0.097 0.007 0.98 0.165 0.138
400 0.104 0.067 0.006 0.97 0.116 0.104
LM_sp(PS2) 100 0.235 0.147 0.009 0.95 0.240 0.236
200 0.144 0.112 0.012 0.96 0.167 0.144
400 0.401 0.361 0.361 0.39 0.165 0.174
Bart 100 0.262 0.183 0.105 0.97 0.271 0.241
200 0.168 0.117 0.076 0.97 0.190 0.150
Continued on next page
5Table S4 – Continued from previous page
Method Sample Size RMSE MAE Bias Rc SEavg SEemp
400 0.130 0.097 0.064 0.96 0.136 0.114
RMSE = root mean square error; MAE = median absolute error; Bias = Estimate-True; Rc = Rate of coverage by the 95% interval estimate;
SEavg = average of standard error estimate from all replicate; SEemp = standard error of ATE estimates from all replicate;
GPMatch: Bayesian structural model with Gaussian process prior, only treatment effect is included in themean function; covariance function
includesX .
QNT_PS: Propensity score sub-classification by quintiles.
AIPTW1&AIPTW2: augmented inversed probability of treatment weighting.
LM_PS1 & LM_PS2: linear regressionmodeling with propensity score adjustment;
LM_sp(PS1) & LM_sp(PS2): linear regressionmodeling with spline fit propensity score adjustment;
BART: Bayesian additive regression tree.
Propensity scores are estimated using different logistic models, with AIPTW1, LM_PS1 & LM_sp(PS1) use PS estimated using logistic model
l og i tA ∼ X ; and AIPTW2, LM_PS2 & LM_sp(PS2) use PS estimated using logistic model l og i tA ∼ X 1/3 . QNT_PS using either PS estimates
produces identical results.
F IGURE S1 Comparisons of root mean square error (RMSE), andmedian absolute error (MAE) of the ATE
Estimates by DifferentMethods Across Different Sample Sizes under the Simulation Setting 1:
{γ0, γ1, γ2, γ3 } = {0.5, 0, 0,
√
0.75}
1 Propensity score estimated using logistic regression on l og i tA ∼ X . 2 Propensity score estimated using logistic
regression on l og i tA ∼ X 1/3. GPMatch: Bayesian structural model with Gaussian process prior. QNT_PS: Propensity
score sub-classification by quintiles. AIPTW: augmented inversed probability of treatment weighting; LM: linear
regressionmodelingY ∼ X ; LM_PS: linear regressionmodeling with propensity score adjustment. LM_sp(PS): linear
regressionmodeling with spline fit propensity score adjustment. BART: Bayesian additive regression tree.
6F IGURE S2 Comparisons of root mean square error (RMSE), andmedian absolute error (MAE) of the ATE
Estimates by DifferentMethods Across Different Sample Sizes under the Simulation Setting 2:
{γ0, γ1, γ2, γ3 } = {1, 0.15, 0, 0}
1 Propensity score estimated using logistic regression on l og i tA ∼ X . 2 Propensity score estimated using logistic
regression on l og i tA ∼ X 1/3. GPMatch: Bayesian structural model with Gaussian process prior. QNT_PS: Propensity
score sub-classification by quintiles. AIPTW: augmented inversed probability of treatment weighting; LM: linear
regressionmodelingY ∼ X ; LM_PS: linear regressionmodeling with propensity score adjustment. LM_sp(PS): linear
regressionmodeling with spline fit propensity score adjustment. BART: Bayesian additive regression tree.
7F IGURE S3 Comparisons of root mean square error (RMSE), andmedian absolute error (MAE) of the ATE
Estimates by DifferentMethods Across Different Sample Sizes under the Simulation Setting 3:
{γ0, γ1, γ2, γ3 } = {0.5, 0, 0.7,
√
0.75}
1 Propensity score estimated using logistic regression on l og i tA ∼ X . 2 Propensity score estimated using logistic
regression on l og i tA ∼ X 1/3. GPMatch: Bayesian structural model with Gaussian process prior. QNT_PS: Propensity
score sub-classification by quintiles. AIPTW: augmented inversed probability of treatment weighting; LM: linear
regressionmodelingY ∼ X ; LM_PS: linear regressionmodeling with propensity score adjustment. LM_sp(PS): linear
regressionmodeling with spline fit propensity score adjustment. BART: Bayesian additive regression tree.
8F IGURE S4 Comparisons of root mean square error (RMSE), andmedian absolute error (MAE) of the ATE
Estimates by DifferentMethods Across Different Sample Sizes under the Simulation Setting 4:
{γ0, γ1, γ2, γ3 } = {1, 0.15, 0.7, 0}
1 Propensity score estimated using logistic regression on l og i tA ∼ X . 2 Propensity score estimated using logistic
regression on l og i tA ∼ X 1/3. GPMatch: Bayesian structural model with Gaussian process prior. QNT_PS: Propensity
score sub-classification by quintiles. AIPTW: augmented inversed probability of treatment weighting; LM: linear
regressionmodelingY ∼ X ; LM_PS: linear regressionmodeling with propensity score adjustment. LM_sp(PS): linear
regressionmodeling with spline fit propensity score adjustment. BART: Bayesian additive regression tree.
9F IGURE S5 Distribution of the Estimated by Different Sample Sizes ATE fromGPMatch under the Kang and Shafer
DualMisspecifcation Setting. Upper panel presents the results of GPMatch with the treatment effect only in themean
functionmodel; lower panel presents the results of GPMatch with the treatment effect and theX1 − X4 in themean
functionmodel. Both includedX1 − X4 in the covariate function.
10
F IGURE S6 Distributions of key covariates in unweighted andweighted samples using inverse probability
weighting of propensity scores for the case study
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